Evidence map›Paper›PMID 42867577›Full record

ArticleAnnals of biomedical engineering2026

The Efficiency-Hemocompatibility Paradox: A Comparative Lagrangian and Eulerian Analysis of Micro-axial p-LVAD Architectures.

Yuval Gabso, Moshe Rosenfeld, Idit Avrahami

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of biomedical engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yuval GabsoSchool of Mechanical Engineering, Tel Aviv University, 69978, Tel Aviv, Israel.
Moshe RosenfeldSchool of Mechanical Engineering, Tel Aviv University, 69978, Tel Aviv, Israel.ORCID http://orcid.org/0000-0002-3008-8053
Idit AvrahamiDepartment of Mechanical Engineering and Mechatronics, Ariel University, P.O. Box 3, 44837, Ariel, Israel. IditAv@Ariel.ac.il.ORCID http://orcid.org/0000-0003-4927-3491

Funding

Ministry of Science and Technology, Israel 3-15642
6 · The paper itself

Abstract

backgroundPercutaneous Left Ventricular Assist Devices (p-LVADs) require a delicate balance between hydraulic efficiency and hemocompatibility. While Eulerian turbulence models offer computational speed, their reliability in predicting mechanical blood damage in complex micro-axial geometries compared to established Lagrangian frameworks remains poorly understood.

methodsWe employed computational fluid dynamics to evaluate four p-LVAD configurations across 20 operating conditions. Models 1-3 utilized a discharge-type architecture, while Model 4 utilized a suction-type configuration with an expanding hub. Hemocompatibility was assessed using two Eulerian turbulence-based indices (HI

resultsA critical design paradox was identified in the suction-type pump: while the expanding hub improved hydraulic efficiency by preventing flow separation, it created a high-velocity bottleneck that significantly elevated bulk shear. Consequently, higher hydraulic efficiency in suction designs was associated with increased Lagrangian blood damage. Eulerian indices functioned primarily as "RPM trackers," showing a near-perfect correlation with the Womersley number (R > 0.94) but failing to capture geometry-induced stress peaks. In contrast, Lagrangian metrics provided a sensitive, multivariate assessment of mechanical loading.

conclusionEulerian models are insufficient for evaluating micro-axial pumps where bulk shear is the dominant damage mechanism. Lagrangian particle tracking (median SA and t

Indexed as

Computational fluid dynamicsHemolysisLagrangian particle trackingMicro-axial pumpPercutaneous left ventricular assist devicePlatelet activation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.